Although PD-1 expression by TILs is the mere hallmark of their physiological activation, PD-L1/2 expression by malignant cells results from several tumor-intrinsic (genetic or oncogenic) and -extrinsic immune escape mechanisms selected by pressure from antitumor immunity. The gene discussed is CD274; the disease is neoplasm.